Skip to main content

Find Clinical Trials

Home
Conditions
Paramedullary Disease

Clinical trial condition

Paramedullary Disease

Explore clinical trials studying Paramedullary Disease. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Paramedullary Disease trial results

Recruiting

A Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Multiple Myeloma (RRMM) With Extramedullary Disease (EMD) and Paramedullary Disease (PMD) "PRIME-EMD-PMD"

NCT07382739

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Elranatamab, +19 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details